These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17127401)

  • 1. Immune control and prevention of chronic Friend retrovirus infection.
    Hasenkrug KJ; Dittmer U
    Front Biosci; 2007 Jan; 12():1544-51. PubMed ID: 17127401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral immunology: lessons from a mouse model.
    Myers L; Hasenkrug KJ
    Immunol Res; 2009; 43(1-3):160-6. PubMed ID: 18830572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses.
    Schlecht-Louf G; Renard M; Mangeney M; Letzelter C; Richaud A; Ducos B; Bouallaga I; Heidmann T
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3782-7. PubMed ID: 20142478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model.
    Hasenkrug KJ; Dittmer U
    Virology; 2000 Jul; 272(2):244-9. PubMed ID: 10873767
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular and molecular mechanisms of vaccine-induced protection against retroviral infections.
    Dittmer U; Hasenkrug KJ
    Curr Mol Med; 2001 Sep; 1(4):431-6. PubMed ID: 11899087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.
    Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM
    Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
    Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
    J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus.
    Zelinskyy G; Dietze K; Sparwasser T; Dittmer U
    PLoS Pathog; 2009 Aug; 5(8):e1000406. PubMed ID: 19714239
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.
    Dittmer U; Brooks DM; Hasenkrug KJ
    J Virol; 1998 Aug; 72(8):6554-8. PubMed ID: 9658099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection.
    Malyshkina A; Littwitz-Salomon E; Sutter K; Zelinskyy G; Windmann S; Schimmer S; Paschen A; Streeck H; Hasenkrug KJ; Dittmer U
    Sci Rep; 2017 Aug; 7(1):7785. PubMed ID: 28798348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection.
    Zelinskyy G; Kraft AR; Schimmer S; Arndt T; Dittmer U
    Eur J Immunol; 2006 Oct; 36(10):2658-70. PubMed ID: 16981182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection.
    Moore TC; Gonzaga LM; Mather JM; Messer RJ; Hasenkrug KJ
    mBio; 2017 Aug; 8(4):. PubMed ID: 28765225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
    Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
    Dittmer U; Hasenkrug KJ
    Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice.
    Hasenkrug KJ; Brooks DM; Dittmer U
    J Virol; 1998 Aug; 72(8):6559-64. PubMed ID: 9658100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.
    Peterson KE; Iwashiro M; Hasenkrug KJ; Chesebro B
    J Virol; 2000 Jun; 74(11):5363-7. PubMed ID: 10799615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprotective determinants in friend murine leukemia virus envelope protein.
    Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
    Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.
    Kato M; Tsuji-Kawahara S; Kawasaki Y; Kinoshita S; Chikaishi T; Takamura S; Fujisawa M; Kawada A; Miyazawa M
    J Virol; 2015 Jan; 89(2):1468-73. PubMed ID: 25378499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.